Annual CFI
$25.00 M
+$49.61 M+201.59%
31 December 2023
Summary:
Cue Biopharma annual cash flow from investing activities is currently $25.00 million, with the most recent change of +$49.61 million (+201.59%) on 31 December 2023. During the last 3 years, it has risen by +$20.55 million (+461.10%). CUE annual CFI is now at all-time high.CUE Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$98.00 K
+$108.00 K+1080.00%
30 September 2024
Summary:
Cue Biopharma quarterly cash flow from investing activities is currently $98.00 thousand, with the most recent change of +$108.00 thousand (+1080.00%) on 30 September 2024. Over the past year, it has dropped by -$4.90 million (-98.04%). CUE quarterly CFI is now -99.35% below its all-time high of $15.00 million, reached on 31 March 2023.CUE Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$33.00 K
-$4.90 M-99.33%
30 September 2024
Summary:
Cue Biopharma TTM cash flow from investing activities is currently $33.00 thousand, with the most recent change of -$4.90 million (-99.33%) on 30 September 2024. Over the past year, it has dropped by -$29.97 million (-99.89%). CUE TTM CFI is now -99.89% below its all-time high of $30.00 million, reached on 30 September 2023.CUE TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CUE Cash From Investing Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +201.6% | -98.0% | -99.9% |
3 y3 years | +461.1% | +990.9% | -99.8% |
5 y5 years | +222.8% | -97.5% | -99.9% |
CUE Cash From Investing High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | at high | +201.6% | -99.3% | +100.3% | -99.9% | +100.1% |
5 y | 5 years | at high | +201.6% | -99.3% | +100.3% | -99.9% | +100.1% |
alltime | all time | at high | +201.6% | -99.3% | +100.3% | -99.9% | +100.1% |
Cue Biopharma Cash From Investing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $98.00 K(-1080.0%) | $33.00 K(-99.3%) |
June 2024 | - | -$10.00 K(-81.8%) | $4.93 M(-50.4%) |
Mar 2024 | - | -$55.00 K(<-9900.0%) | $9.95 M(-60.2%) |
Dec 2023 | $25.00 M(-201.6%) | $0.00(-100.0%) | $25.00 M(-16.7%) |
Sept 2023 | - | $5.00 M(0.0%) | $30.00 M(-763.9%) |
June 2023 | - | $5.00 M(-66.7%) | -$4.52 M(-52.8%) |
Mar 2023 | - | $15.00 M(+200.1%) | -$9.58 M(-61.1%) |
Dec 2022 | -$24.61 M(-370.2%) | $5.00 M(-116.9%) | -$24.61 M(-16.9%) |
Sept 2022 | - | -$29.52 M(>+9900.0%) | -$29.61 M(>+9900.0%) |
June 2022 | - | -$62.00 K(+129.6%) | -$99.50 K(-63.2%) |
Mar 2022 | - | -$27.00 K(-5500.0%) | -$270.50 K(-103.0%) |
Dec 2021 | $9.11 M(+104.4%) | $500.00(-104.5%) | $9.11 M(-52.1%) |
Sept 2021 | - | -$11.00 K(-95.3%) | $19.00 M(-19.7%) |
June 2021 | - | -$233.00 K(-102.5%) | $23.66 M(-0.4%) |
Mar 2021 | - | $9.35 M(-5.5%) | $23.76 M(+433.2%) |
Dec 2020 | $4.46 M | $9.89 M(+112.5%) | $4.46 M(-121.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2020 | - | $4.65 M(-3424.3%) | -$20.58 M(-3.2%) |
June 2020 | - | -$140.00 K(-98.6%) | -$21.25 M(+33.0%) |
Mar 2020 | - | -$9.95 M(-34.3%) | -$15.98 M(-563.7%) |
Dec 2019 | $3.45 M(-116.9%) | -$15.15 M(-480.2%) | $3.45 M(-85.2%) |
Sept 2019 | - | $3.98 M(-22.3%) | $23.28 M(-639.7%) |
June 2019 | - | $5.13 M(-45.9%) | -$4.31 M(-57.7%) |
Mar 2019 | - | $9.48 M(+102.3%) | -$10.20 M(-49.9%) |
Dec 2018 | -$20.35 M(+1589.1%) | $4.69 M(-119.9%) | -$20.35 M(-18.8%) |
Sept 2018 | - | -$23.61 M(+3006.3%) | -$25.06 M(+1409.6%) |
June 2018 | - | -$760.00 K(+12.9%) | -$1.66 M(+25.6%) |
Mar 2018 | - | -$673.00 K(+3442.1%) | -$1.32 M(+9.7%) |
Dec 2017 | -$1.21 M(+133.5%) | -$19.00 K(-90.9%) | -$1.21 M(+1.6%) |
Sept 2017 | - | -$208.00 K(-50.7%) | -$1.19 M(+21.3%) |
June 2017 | - | -$422.00 K(-24.1%) | -$978.00 K(+75.9%) |
Mar 2017 | - | -$556.00 K | -$556.00 K |
Dec 2016 | -$516.00 K(-35.8%) | - | - |
Dec 2015 | -$804.30 K | - | - |
FAQ
- What is Cue Biopharma annual cash flow from investing activities?
- What is the all time high annual CFI for Cue Biopharma?
- What is Cue Biopharma annual CFI year-on-year change?
- What is Cue Biopharma quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Cue Biopharma?
- What is Cue Biopharma quarterly CFI year-on-year change?
- What is Cue Biopharma TTM cash flow from investing activities?
- What is the all time high TTM CFI for Cue Biopharma?
- What is Cue Biopharma TTM CFI year-on-year change?
What is Cue Biopharma annual cash flow from investing activities?
The current annual CFI of CUE is $25.00 M
What is the all time high annual CFI for Cue Biopharma?
Cue Biopharma all-time high annual cash flow from investing activities is $25.00 M
What is Cue Biopharma annual CFI year-on-year change?
Over the past year, CUE annual cash flow from investing activities has changed by +$49.61 M (+201.59%)
What is Cue Biopharma quarterly cash flow from investing activities?
The current quarterly CFI of CUE is $98.00 K
What is the all time high quarterly CFI for Cue Biopharma?
Cue Biopharma all-time high quarterly cash flow from investing activities is $15.00 M
What is Cue Biopharma quarterly CFI year-on-year change?
Over the past year, CUE quarterly cash flow from investing activities has changed by -$4.90 M (-98.04%)
What is Cue Biopharma TTM cash flow from investing activities?
The current TTM CFI of CUE is $33.00 K
What is the all time high TTM CFI for Cue Biopharma?
Cue Biopharma all-time high TTM cash flow from investing activities is $30.00 M
What is Cue Biopharma TTM CFI year-on-year change?
Over the past year, CUE TTM cash flow from investing activities has changed by -$29.97 M (-99.89%)